Skip to Main Content

Paper Details

A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
BMC Cancer
41
2018
Author NameAffiliation
Yusuke NakamuraHuman Genome Center, Institute of Medical Science, The University of Tokyo
Yusuke NakamuraThe University of Chicago
  • 1 - 2

Datasets

Release 1.2